SCHEMBL1801715

SCHEMBL1801715

CC1(C)O[C@@H]2[C@H](O1)[C@@H](CNS(N)(=O)=O)O[C@H]2n1cnc2c(CCc3ccccc3)ncnc21

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.50
PI4KA P42356 1/20 0.49
PI4K2B Q8TCG2 1/20 0.49
PI4K2A Q9BTU6 1/20 0.49
PI4KB Q9UBF8 1/20 0.49
P2RX1 P51575 1/20 0.43
P2RX3 P56373 1/20 0.43
P2RX4 Q99571 1/20 0.43
ADORA3 P0DMS8 4/20 0.42
ADORA2A P29274 3/20 0.42
ADORA1 P30542 3/20 0.42
NFKB1 P19838 1/20 0.42
THPO P40225 1/20 0.42
TSHR P16473 1/20 0.42
AMD1 P17707 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1800449 0.88 RXFP1 (0.61) RXFP1PI4KAPI4K2BPI4K2API4KB
SCHEMBL1799458 0.84 PI4KA (0.66) RXFP1PI4KAPI4K2BPI4K2API4KB
SCHEMBL1800390 0.83 RXFP1 (0.57) RXFP1PI4KAPI4K2BPI4K2API4KB
SCHEMBL18314858 0.83 PI4KA (0.70) RXFP1PI4KAPI4K2BPI4K2API4KB
SCHEMBL1799357 0.83 RXFP1 (0.57) RXFP1PI4KAPI4K2BPI4K2API4KB
SCHEMBL1945010 0.83 RXFP1 (0.49) RXFP1PI4KAPI4K2BPI4K2API4KB
SCHEMBL1801717 0.83 RXFP1 (0.49) RXFP1PI4KAPI4K2BPI4K2API4KB
SCHEMBL5319771 0.83 RXFP1 (0.56) RXFP1PI4KAPI4K2BPI4K2API4KB
SCHEMBL1794414 0.83 RXFP1 (0.56) RXFP1PI4KAPI4K2BPI4K2API4KB
SCHEMBL24450944 0.81 RXFP1 (0.56) RXFP1PI4KAPI4K2BPI4K2API4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951810-B2 Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of E1 activating enzymes MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-05-31 US disclosed